UCSF Expert: Pfizer COVID Antiviral Pill Would Be A Game Changer
Pfizer's Friday announcement that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults could be a game changer in the treatment of the virus. At least that was initial opinion of UCSF Professor of Medicine and Infections Disease Dr. Monica Gandhi.